IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP II, LLC

Q1 2019 Holdings

Filed 2019-05-03 | 3 holdings | $153.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Blueprint Medicines Corporation(2L9)COM09627Y109$70.4K878,87545.9%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$63.4K10,230,34941.4%
Allena Pharmaceuticals, Inc.(ALNAEUR)COM018119107$19.6K2,790,96412.8%